{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:29:17Z","timestamp":1761128957275},"reference-count":29,"publisher":"Japanese Society of Allergology","issue":"4","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000},"content-version":"vor","delay-in-days":1579,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2011]]},"DOI":"10.2332\/allergolint.11-rai-0362","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T06:14:23Z","timestamp":1323756863000},"page":"419-424","source":"Crossref","is-referenced-by-count":18,"title":["2009 ESC\/ERS Pulmonary Hypertension Guidelines and Connective Tissue Disease"],"prefix":"10.2332","volume":"60","author":[{"given":"Norifumi","family":"Nakanishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1154","reference":[{"issue":"Suppl","key":"10.2332\/allergolint.11-RAI-0362_bb0005","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0010","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Galie","year":"2009","journal-title":"Eur Heart J"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0015","unstructured":"Rich S, Rubin LJ, Abenhail L et al: Executive summary from the World Symposium on Primary Pulmonary Hypertension (Evian, France, September 6\u201310, 1998). The World Health Organization publication via the Internet. Available at: http:\/\/www.who.int\/ncd\/cvd\/pph.html."},{"key":"10.2332\/allergolint.11-RAI-0362_bb0020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/01.CIR.18.4.533","article-title":"The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects","volume":"18","author":"Heath","year":"1958","journal-title":"Circulation"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0025","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jacc.2004.02.037","article-title":"Clinical classification of pulmonary hypertension","volume":"43","author":"Simonneau","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/79226","article-title":"Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension","volume":"26","author":"The International PPH Consortium","year":"2000","journal-title":"Nat Genet"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0035","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM200108023450503","article-title":"Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia","volume":"345","author":"Trembath","year":"2001","journal-title":"N Engl J Med"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0040","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","article-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study","volume":"52","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0045","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","article-title":"Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach","volume":"62","author":"Mukerjee","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0050","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/art.22069","article-title":"Clinical differences between idiopathic and scleroderma-related pulmonary hypertension","volume":"54","author":"Fisher","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0055","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/hep.21431","article-title":"Portopulmonary hypertension: Results from a 10- year screening algorithm","volume":"44","author":"Krowka","year":"2006","journal-title":"Hepatology"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0060","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1183\/09031936.98.11051153","article-title":"Pulmonary vascular disorders in portal hypertension","volume":"11","author":"Herv\u00e9","year":"1998","journal-title":"Eur Respir J"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0065","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0735-1097(87)80123-7","article-title":"Coexistent pulmonary and portal hypertension: morphologic and clinical features","volume":"10","author":"Edwards","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0070","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2165\/00003495-200868080-00004","article-title":"Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger\u2019s syndrome","volume":"68","author":"Galie","year":"2008","journal-title":"Drugs"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/09031936.00090608","article-title":"Pulmonary venoocclusive disease","volume":"33","author":"Montani","year":"2009","journal-title":"Eur Respir J"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(00)01102-5","article-title":"Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure","volume":"37","author":"Ghio","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0085","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1378\/chest.129.3.746","article-title":"Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis","volume":"129","author":"Lettieri","year":"2006","journal-title":"Chest"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0090","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1183\/09031936.05.00021005","article-title":"Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity","volume":"26","author":"Cottin","year":"2005","journal-title":"Eur Respir J"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0095","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1183\/09031936.93.05030334","article-title":"Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment","volume":"5","author":"Moser","year":"1992","journal-title":"Eur Respir J"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2214\/ajr.144.1.27","article-title":"Perfusion lung scanning: differentiation of primary from thromboembolic pulmonary hypertension","volume":"144","author":"Lisbona","year":"1985","journal-title":"AJR Am J Roentgenol"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0110","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0115","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1183\/09031936.05.00054804","article-title":"Survival with first-line bosentan in patients with primary pulmonary hypertension","volume":"25","author":"McLaughlin","year":"2005","journal-title":"Eur Respir J"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0120","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Gali\u00e8","year":"2008","journal-title":"Circulation"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0125","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Gali\u00e8","year":"2005","journal-title":"N Engl J Med"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0130","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Gali\u00e8","year":"2009","journal-title":"Circulation"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0135","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0735-1097(02)01786-2","article-title":"Effects of bera-prost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial","volume":"39","author":"Gali\u00e8","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0140","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.2332\/allergolint.11-RAI-0362_bb0145","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.23303","article-title":"Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases","volume":"58","author":"Jais","year":"2008","journal-title":"Arthritis Rheum"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1323893015305487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1323893015305487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T19:16:37Z","timestamp":1686510997000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893015305487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"alternative-id":["S1323893015305487"],"URL":"https:\/\/doi.org\/10.2332\/allergolint.11-rai-0362","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}